Vaccine against COVID-19
BBV152 ▸ Facts ▸ Comments ▸ News ▸ Videos
Watch: Nepal's Foreign Minister meets EAM Jaishankar in Delhi l Key details
Credit: HT Digital Content Duration: 02:30Published
Covaxin, Covishield are safe, there is no difference between both: Shivraj Chouhan
Credit: ANI Duration: 01:47Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist
Credit: HT Digital Content Duration: 04:36Published
Covishield and Covaxin are safe, assures ICMR scientist
Credit: ANI Duration: 02:29Published
Covaxin's immunity will address mutants too: ICMR scientist
Credit: ANI Duration: 01:24Published
‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval
Credit: HT Digital Content Duration: 01:40Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch
Credit: HT Digital Content Duration: 02:39Published
Indians are not guinea pigs: Manish Tewari on rollout of Covaxin
Credit: ANI Duration: 01:10Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield
Credit: HT Digital Content Duration: 02:02Published
First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport
Credit: ANI Duration: 01:18Published
Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out
Credit: HT Digital Content Duration: 03:31Published
‘Both vaccines are safe for use’: Centre ahead of vaccination roll-out in India
Credit: HT Digital Content Duration: 07:42Published
Covid: How much will Covishield, Covaxin, other vaccines cost? Centre reveals
Credit: HT Digital Content Duration: 06:57Published
BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry
Credit: ANI Duration: 01:23Published
Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy
Credit: ANI Duration: 02:22Published
Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move
Credit: HT Digital Content Duration: 03:58Published
You Might Like
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
Bharat Biotech commences dispatch of Covaxin, ships to 11 citiesVaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier..
After Covishield, first batch of Bharat Biotech's Covaxin arrives in DelhiBoth Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.
Covid vaccine recipients may not be able to pick & chooseEven as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK PaulCovishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member..
Bharat Biotech inks pact to supply Covaxin to BrazilVaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian..
Gas activists request PM to stop vaccine trials in BhopalOrganisations working with Bhopal gas disaster victims on Sunday urged PM Modi to stop the clinical trial of Covaxin in Bhopal, alleging irregularities in process and protocol. The activists have..
Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-MarchBuoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
Supply order for Covid vax likely to be placed todayCovishield and Covaxin, the two vaccines accorded emergency use approval, are on the verge of being available in the country, health minister Harsh Vardhan said on Thursday, adding that a mega..
Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials
Covid-19 vaccines 'Covishield', 'Covaxin' to be available soon in India
No irregularity in approval to Covaxin: ICMRIn an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
Zee News journalist, who had taken Covaxin shot, feels feverish the day afterZee News reporter Pooja Makkar, who became the first Indian woman journalist to receive the indigenously developed COVID-19 vaccine 'Covaxin', on Tuesday evening said that she has a slight fever and a..
Carried out 200% honest trials, don't deserve this backlash: Bharat Biotech hits back at criticsSome opposition leaders and scientific researchers criticised Covaxin for being given emergency use authorisation without completion of phase 3 trials
Vaccine war: Bharat Biotech chief lashes out at SerumBharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was given to Covaxin, the company’s Covid-19..
Covaxin not water-like or backup vaccine, trials 200% honest: Bharat Biotech CEO
Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday. "We have four facilities coming up and we are planning (to make) around 200 million doses in..
'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being "targeted by everyone in the world" for..
DCGI allows Bharat Biotech to conduct vaccine trials on children above 12Covaxin has already been used on children above 12 in phase I and II trials and has been found safe.
Covid: Both vaccines get final nod, first shots to be of CovishieldThe Serum Institute of India’s Covishield is likely to be first shot used in India’s vaccine drive against Covid-19. For Covaxin, the authorisation is in clinical-trial mode, which means that..
Vaccine approval process opaque: ExpertsFormer president of the International Association of Bioethics, Dr Anant Bhan, pointed out that the only other countries to approve vaccines without making the efficacy data public were Russia and..
ICMR says clinical trial shows COVAXIN is 'safe'Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
Covid-19: India approves Covaxin and Covishield vaccines; Congress expresses concern over Covaxin trial data
Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to CovaxinThe Hyderabad-based vaccine maker expressed its delight after DCGI granted permission for emergency use of its Covid-19 vaccine.
'Watershed moment in India's battle against COVID': Politicos react over emergency use approvalDCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
DCGI approves Oxford's Covishield and Bharat Biotech's Covaxin vaccines for restricted emergency use
COVID-19: Bharat Biotech recruits 23,000 volunteers for Phase III trials of CovaxinThe phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.
Also reported by •IndiaTimes
Bharat Biotech’s Covaxin too gets nod for emergency useIndia's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
After Covishield, India's Covaxin gets expert panel nod for emergency useAn expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly
No approval for Covaxin, expert panel seeks more data from Bharat BiotechThe Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for..
Covaxin can offer protection against mutated coronavirus: Bharat BiotechVaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah NaiduThey discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
Indian vaccine Covaxin has drawn global attention: ICMRThe Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
Covaxin Phase III trials hit halfway mark with 13K volunteersCovaxin, India's first indigenous Covid-19 vaccine being developed by Hyderabad-based Bharat Biotech, has been successful in roping in 13,000 volunteers for its Phase III trials, which is half the..